Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li C Liu

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Diseases of the Colon and Rectum|February 27, 2024
Socioeconomic Disparities in Anal Cancer: Effect on Treatment Delay and SurvivalPramod Nepal, Muhammad H Zafar, Li C Liu, et al.
American Journal of Clinical Oncology|April 12, 2019
Phase I Study of Aurora A Kinase Inhibitor Alisertib (MLN8237) in Combination With Selective VEGFR Inhibitor Pazopanib for Therapy of Advanced Solid TumorsHiral A Shah, James H Fischer, Neeta K Venepalli, et al.
Journal of Environmental Monitoring : JEM|August 10, 2011
A comparison of rapid and conventional measures of indicator bacteria as predictors of waterborne protozoan pathogen presence and densitySamuel Dorevitch, Mary Doi, Fu-Chih Hsu, et al.
Journal of Clinical Apheresis|May 28, 2021
Race/ethnicity and underlying disease influences hematopoietic stem/progenitor cell mobilization response: A single center experienceChukwuemeka Uzoka, Li C Liu, Youngmin Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2020
Phase Ib/II Clinical Trial of Pembrolizumab With Bevacizumab for Metastatic Renal Cell Carcinoma: BTCRC-GU14-003Arkadiusz Z Dudek, Li C Liu, Shilpa Gupta, et al.
American Journal of Clinical Oncology|October 22, 2019
Phase I Study of IGF-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1RNeeta K Venepalli, Rajyasree Emmadi, Oana C Danciu, et al.
Breast Cancer Research and Treatment|July 23, 2020
Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapyArkadiusz Z Dudek, Li C Liu, James H Fischer, et al.
British Journal of Cancer|December 5, 2022
Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignanciesOana C Danciu, Matthias Holdhoff, Richard A Peterson, et al.
Neuro-Oncology Advances|August 9, 2023
Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomasMatthias Holdhoff, M Kelly Nicholas, Richard A Peterson, et al.
Plos One|June 18, 2025
Group antenatal care positively transforms the care experience: Results of an effectiveness trial in MalawiCrystal L Patil, Kathleen F Norr, Esnath Kapito, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Diseases of the Colon and Rectum|February 27, 2024
Socioeconomic Disparities in Anal Cancer: Effect on Treatment Delay and SurvivalPramod Nepal, Muhammad H Zafar, Li C Liu, et al.
American Journal of Clinical Oncology|April 12, 2019
Phase I Study of Aurora A Kinase Inhibitor Alisertib (MLN8237) in Combination With Selective VEGFR Inhibitor Pazopanib for Therapy of Advanced Solid TumorsHiral A Shah, James H Fischer, Neeta K Venepalli, et al.
Journal of Environmental Monitoring : JEM|August 10, 2011
A comparison of rapid and conventional measures of indicator bacteria as predictors of waterborne protozoan pathogen presence and densitySamuel Dorevitch, Mary Doi, Fu-Chih Hsu, et al.
Journal of Clinical Apheresis|May 28, 2021
Race/ethnicity and underlying disease influences hematopoietic stem/progenitor cell mobilization response: A single center experienceChukwuemeka Uzoka, Li C Liu, Youngmin Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2020
Phase Ib/II Clinical Trial of Pembrolizumab With Bevacizumab for Metastatic Renal Cell Carcinoma: BTCRC-GU14-003Arkadiusz Z Dudek, Li C Liu, Shilpa Gupta, et al.
American Journal of Clinical Oncology|October 22, 2019
Phase I Study of IGF-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1RNeeta K Venepalli, Rajyasree Emmadi, Oana C Danciu, et al.
Breast Cancer Research and Treatment|July 23, 2020
Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapyArkadiusz Z Dudek, Li C Liu, James H Fischer, et al.
British Journal of Cancer|December 5, 2022
Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignanciesOana C Danciu, Matthias Holdhoff, Richard A Peterson, et al.
Neuro-Oncology Advances|August 9, 2023
Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomasMatthias Holdhoff, M Kelly Nicholas, Richard A Peterson, et al.
Plos One|June 18, 2025
Group antenatal care positively transforms the care experience: Results of an effectiveness trial in MalawiCrystal L Patil, Kathleen F Norr, Esnath Kapito, et al.
Pageof 2